AI-GUIDE AI device for catheter insertion in the field moves from MIT Lincoln Laboratory to commercial production
The AI-GUIDE device from MIT Lincoln Laboratory and Massachusetts General Hospital for assisted catheter insertion in the field received the 2026 Excellence in Technology Transfer Award and is heading toward commercial production at the startup AutonomUS Medical Technologies; according to the company, it also has FDA Breakthrough Device Designation.
Federal Laboratory Consortium presented the AI-GUIDE device, developed by the companies MIT Lincoln Laboratory and Massachusetts General Hospital, with the 2026 Excellence in Technology Transfer Award. Development was funded by the U.S. Army Combat Casualty Care Research Program, and the device is now being transferred to commercial production at the startup AutonomUS Medical Technologies.
AI-GUIDE is a portable device combining commercial handheld ultrasound technology with proprietary AI software to help the user insert a guidewire and catheter into a blood vessel in a patient. Unlike standard hospital ultrasound machines, it is small and portable, which, according to its developers, makes it particularly suited to use in the field – primarily by military medics who must keep injured soldiers alive until they can be evacuated to a hospital, but also by civilian emergency responders.
According to the source, the journey from an idea to a working prototype and the founding of a startup took three years. AutonomUS Medical Technologies subsequently received Breakthrough Device Designation from FDA, an accelerated regulatory pathway reserved for highly innovative technologies with the potential to save lives, as well as a Small Business Innovation Research grant from U.S. Department of the Air Force and additional funding from private investors, Department of War and National Institutes of Health.
According to the source, the team is also developing and preparing to transfer additional capabilities of the device, including technology for peripheral nerve blocks intended for trauma care and pain relief. AI-GUIDE previously also received the Lincoln Laboratory Best Invention Award and R&D 100 Award.
Why it matters
For military and civilian emergency responders, this is a tool that, according to its developers, enables even minimally trained personnel to perform procedures otherwise available only in a hospital, which could improve the chances of survival for injured people in the field. For institutions and companies in medtech and defense technology, it is a documented example of how federally funded research can move through the FDA regulatory pathway and reach commercial launch.
Relevant practical impact
What this means
For a business
The case demonstrates a working model for transferring technology from federally funded research (a military program, MIT Lincoln Laboratory, hospitals) to a startup, including the use of the accelerated FDA Breakthrough Device Designation regulatory pathway and combined funding from public grants and private investors – a relevant model for companies and institutions operating in medtech…
DevelopmentCheck the original
Event sources
only one source so far · 1 publisher, 1 independent. We count feeds from the same owner only once.